Predictmedix Inc.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, VMD.TO has a market cap of 402.2M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while VMD.TO trades at CA$10.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas VMD.TO's P/E ratio is 32.66. In terms of profitability, PMED.CN's ROE is +2.13%, compared to VMD.TO's ROE of +0.06%. Regarding short-term risk, PMED.CN is less volatile compared to VMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, PRN.TO has a market cap of 243.4M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while PRN.TO trades at CA$8.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas PRN.TO's P/E ratio is -4.88. In terms of profitability, PMED.CN's ROE is +2.13%, compared to PRN.TO's ROE of -0.71%. Regarding short-term risk, PMED.CN is less volatile compared to PRN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, TMD.TO has a market cap of 128.3M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while TMD.TO trades at CA$1.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas TMD.TO's P/E ratio is -0.65. In terms of profitability, PMED.CN's ROE is +2.13%, compared to TMD.TO's ROE of -1.36%. Regarding short-term risk, PMED.CN is less volatile compared to TMD.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, NVCN.TO has a market cap of 110.8M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while NVCN.TO trades at CA$40.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas NVCN.TO's P/E ratio is -1.96. In terms of profitability, PMED.CN's ROE is +2.13%, compared to NVCN.TO's ROE of -1.21%. Regarding short-term risk, PMED.CN is less volatile compared to NVCN.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, QIPT.TO has a market cap of 106M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while QIPT.TO trades at CA$2.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas QIPT.TO's P/E ratio is -8.41. In terms of profitability, PMED.CN's ROE is +2.13%, compared to QIPT.TO's ROE of -0.07%. Regarding short-term risk, PMED.CN is less volatile compared to QIPT.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, BLO.CN has a market cap of 72.5M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while BLO.CN trades at CA$0.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas BLO.CN's P/E ratio is -21.00. In terms of profitability, PMED.CN's ROE is +2.13%, compared to BLO.CN's ROE of -0.89%. Regarding short-term risk, PMED.CN is less volatile compared to BLO.CN. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, ATE.TO has a market cap of 15.6M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while ATE.TO trades at CA$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas ATE.TO's P/E ratio is -0.84. In terms of profitability, PMED.CN's ROE is +2.13%, compared to ATE.TO's ROE of -0.40%. Regarding short-term risk, PMED.CN is less volatile compared to ATE.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, MYTC.CN has a market cap of 4M. Regarding current trading prices, PMED.CN is priced at CA$0.02, while MYTC.CN trades at CA$0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas MYTC.CN's P/E ratio is -3.00. In terms of profitability, PMED.CN's ROE is +2.13%, compared to MYTC.CN's ROE of +1.15%. Regarding short-term risk, PMED.CN and MYTC.CN have similar daily volatility (0.00).

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, ASTI.CN has a market cap of 690K. Regarding current trading prices, PMED.CN is priced at CA$0.02, while ASTI.CN trades at CA$0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas ASTI.CN's P/E ratio is -0.83. In terms of profitability, PMED.CN's ROE is +2.13%, compared to ASTI.CN's ROE of +0.18%. Regarding short-term risk, PMED.CN and ASTI.CN have similar daily volatility (0.00).

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, IME.CN has a market cap of 162.5K. Regarding current trading prices, PMED.CN is priced at CA$0.02, while IME.CN trades at CA$0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas IME.CN's P/E ratio is -0.19. In terms of profitability, PMED.CN's ROE is +2.13%, compared to IME.CN's ROE of +0.20%. Regarding short-term risk, PMED.CN and IME.CN have similar daily volatility (0.00).

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, AVBT.CN has a market cap of 123.7K. Regarding current trading prices, PMED.CN is priced at CA$0.02, while AVBT.CN trades at CA$0.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas AVBT.CN's P/E ratio is -0.20. In terms of profitability, PMED.CN's ROE is +2.13%, compared to AVBT.CN's ROE of +4.09%. Regarding short-term risk, PMED.CN and AVBT.CN have similar daily volatility (0.00).

PMED.CN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, PMED.CN stands at 4.8M. In comparison, HSM.TO has a market cap of 0. Regarding current trading prices, PMED.CN is priced at CA$0.02, while HSM.TO trades at CA$18.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

PMED.CN currently has a P/E ratio of -1.00, whereas HSM.TO's P/E ratio is -1.73. In terms of profitability, PMED.CN's ROE is +2.13%, compared to HSM.TO's ROE of -2.91%. Regarding short-term risk, PMED.CN is less volatile compared to HSM.TO. This indicates potentially lower risk in terms of short-term price fluctuations for PMED.CN.